Functional Imaging in the Assessment of mRCC Response to Sunitinib

The aim of this study is to assess whether functional magnetic resonance imaging (MRI) techniques are able to detect which patients with metastatic renal cell carcinoma will derive benefit from treatment with sunitinib early in their treatment. Early response assessment would allow selection of the most appropriate treatment option for each individual patient.